+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pneumothorax Treatment Devices Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6284017
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pneumothorax Treatment Devices: Executive Overview

Pneumothorax treatment devices support the evacuation of pleural air, restoration of lung expansion, and monitoring of patients across emergency, inpatient, procedural, and selected outpatient settings. Clinical adoption is shaped by pneumothorax type, severity, recurrence risk, patient stability, local protocols, and clinician capability. Core device categories include needle and catheter-based systems, chest drainage systems, Heimlich-type valves, digital air-leak monitoring technologies, and accessories used for insertion, fixation, and drainage management. The market is influenced by demand for dependable emergency care, less invasive treatment pathways, infection-control performance, portability, and ease of use rather than by a single device attribute.

Care Pathways Are Shifting Toward Simpler, More Controlled Drainage

Treatment pathways are evolving from routine inpatient chest-tube management toward more selective use of small-bore catheters, ambulatory drainage options, and protocol-guided observation when clinically appropriate. This shift reflects efforts to reduce procedural burden, shorten hospital stays, and improve patient mobility while preserving safety. Product differentiation increasingly centers on atraumatic insertion, secure fixation, low resistance to drainage, prevention of accidental disconnection, and clear status visibility. Hospitals are also placing greater emphasis on standardized bundles covering insertion technique, analgesia, imaging confirmation, drain maintenance, and removal criteria.

Artificial Intelligence Strengthens Detection, Triage, and Drainage Decisions

Artificial intelligence can contribute across the pneumothorax pathway by supporting image interpretation, flagging suspected pleural air on radiographs or computed tomography, and prioritizing cases for review. When integrated with clinical information, AI may help distinguish urgent presentations from cases suitable for observation or planned intervention. In device management, analytics can assist with trend recognition in air-leak data and identify patterns that warrant reassessment. Safe implementation requires representative validation, transparent performance measures, clinician oversight, cybersecurity controls, and careful management of false positives and false negatives. AI should augment-not replace-clinical judgment, procedural expertise, and direct patient assessment.

Regional Priorities Differ by Emergency Capacity and Care Continuity

In North America, mature emergency systems support adoption of advanced drainage, monitoring, and ambulatory-care tools, with strong attention to evidence, workflow efficiency, and infection prevention. Latin America presents varied access to thoracic expertise, imaging, and reliable supply, increasing the value of robust, straightforward devices and training programs. Europe emphasizes standardized clinical pathways, patient safety, sustainability, and evidence-based device selection across diverse health systems. In the Middle East, expanding specialist infrastructure and referral networks create demand for dependable emergency and hospital-based drainage solutions. Africa requires products suited to resource variability, transport limitations, maintenance constraints, and workforce development. Asia-Pacific combines sophisticated tertiary centers with high-volume and resource-constrained settings, favoring scalable portfolios, local training, and devices adaptable to different care environments.

Economic and Alliance Groups Highlight Different Implementation Needs

Across ASEAN, uneven hospital capacity and cross-border variation make portability, usability, training, and supply continuity important considerations. BRICS economies span advanced centers and resource-limited facilities, creating demand for tiered solutions that can be deployed across different levels of care without compromising core safety. The European Union places substantial weight on regulatory compliance, clinical evidence, interoperability, and sustainability. G7 health systems generally prioritize quality assurance, workflow integration, patient experience, and post-market surveillance. GCC countries often combine advanced hospital investment with centralized procurement and specialist referral models, supporting demand for reliable, high-performance systems. NATO members must also consider emergency preparedness, logistics resilience, interoperability, and the ability to maintain trauma-care capability during surges or disruptions.

Country Conditions Shape Device Selection and Adoption

In Australia, geographic distance increases the importance of portable care and transfer-ready drainage systems. Brazil and Mexico face variation in access between major urban centers and other regions, making training, distribution, and dependable basic devices central priorities. Canada must address dispersed populations and transport pathways alongside advanced hospital standards. China and India combine large patient populations with substantial differences in facility capability, supporting both sophisticated tertiary solutions and scalable products for broader deployment. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom have established specialist services, with attention to protocol standardization, safety, efficiency, and healthcare-resource stewardship. Russia requires consideration of regional access, procurement continuity, and supply resilience. In the United States, emergency-care integration, ambulatory pathways, data-enabled monitoring, and evidence-supported workflow improvements are prominent selection factors.

Industry Leaders Should Prioritize Safety, Usability, and System Integration

Leaders should align product development with clearly defined clinical use cases, distinguishing emergency decompression, definitive drainage, postoperative management, and ambulatory care. Design priorities should include intuitive insertion support, secure connections, effective air and fluid handling, reliable alarms or indicators, and straightforward removal workflows. Evidence generation should measure clinically meaningful outcomes such as complications, time to lung re-expansion, unplanned interventions, patient mobility, and readmissions. Organizations should build region-specific training, service, and distribution models; protect supply continuity through qualified alternatives; and ensure compatibility with imaging, documentation, and hospital information workflows. AI-enabled features should be introduced through staged validation and governance, with explicit accountability for clinical review and data protection.

Methodology Combines Clinical, Regulatory, and Operational Evidence

This executive summary uses a structured review framework focused on pneumothorax treatment-device applications, care settings, technology characteristics, and adoption conditions. Analysis should triangulate peer-reviewed clinical literature, professional guidelines, regulatory documents, hospital protocols, procurement practices, product labeling, and publicly available health-system information. Findings are organized by geography and economic or alliance grouping to identify differences in infrastructure, workforce, access, and policy. Qualitative synthesis is used to distinguish established practices from emerging approaches, while claims are limited to verifiable clinical, operational, and regulatory observations. No market estimates, market sizing, market shares, or forecasts are used.

The Winning Proposition Is Dependable Treatment Across Diverse Care Settings

Pneumothorax treatment-device adoption will be shaped by the ability to deliver safe, controlled, and practical care across emergency departments, operating rooms, inpatient wards, ambulatory pathways, and transport settings. Products that combine procedural simplicity with dependable drainage, secure handling, clear monitoring, and strong training support are positioned to address the broadest operational needs. Regional and country differences require flexible implementation rather than a one-size-fits-all approach. Sustained progress will depend on clinical evidence, resilient supply, responsible digital integration, and close alignment between device design and real-world care pathways.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pneumothorax Treatment Devices Market, by Type of Device
7.1. Introduction
7.2. Chest Tubes (Thoracostomy Tubes)
7.3. Needle Decompression Kits
7.4. Thoracic Catheters
7.5. Pneumothorax Valves
7.6. Surgical and Minimally Invasive Devices
7.7. Ambu Bags with Ventilation
8. Pneumothorax Treatment Devices Market, by Treatment Method
8.1. Introduction
8.2. Conservative Treatment Devices
8.3. Needle Aspiration Devices
8.4. Chest Drainage Systems
8.5. Surgical Treatment Devices
9. Pneumothorax Treatment Devices Market, by Age Group
9.1. Introduction
9.2. Pediatric Pneumothorax Treatment Devices
9.3. Adult Pneumothorax Treatment Devices
10. Pneumothorax Treatment Devices Market, by Application
10.1. Introduction
10.2. Spontaneous Pneumothorax
10.3. Traumatic Pneumothorax
10.4. Tension Pneumothorax
10.5. Iatrogenic Pneumothorax
10.6. Post-Surgical Pneumothorax
11. Pneumothorax Treatment Devices Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Pneumothorax Treatment Devices Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Pneumothorax Treatment Devices Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Becton, Dickinson and Company
15.2. Chembio Diagnostics, Inc.
15.3. ConvaTec Group Plc
15.4. Cook Medical Inc.
15.5. Getinge AB
15.6. Halyard Health, Inc.
15.7. Johnson & Johnson
15.8. Livanova PLC
15.9. Medi-Globe GmbH
15.10. Medtronic plc
15.11. Pneumothorax Solutions, Inc.
15.12. Smith & Nephew plc
15.13. Sorin Group
15.14. Teleflex Incorporated
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Pneumothorax Treatment Devices Market, Years Considered for the Study
FIGURE 2. Global Pneumothorax Treatment Devices Market, Research Design
FIGURE 3. Global Pneumothorax Treatment Devices Market, Research Framework
FIGURE 4. Global Pneumothorax Treatment Devices Market, Data Triangulation
FIGURE 5. Global Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pneumothorax Treatment Devices Market Size, by Type of Device, 2025 vs 2032 (%)
FIGURE 7. Global Pneumothorax Treatment Devices Market Size, by Type of Device, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pneumothorax Treatment Devices Market Size, by Treatment Method, 2025 vs 2032 (%)
FIGURE 9. Global Pneumothorax Treatment Devices Market Size, by Treatment Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pneumothorax Treatment Devices Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 11. Global Pneumothorax Treatment Devices Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pneumothorax Treatment Devices Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Pneumothorax Treatment Devices Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pneumothorax Treatment Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Pneumothorax Treatment Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pneumothorax Treatment Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Pneumothorax Treatment Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Pneumothorax Treatment Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Pneumothorax Treatment Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Pneumothorax Treatment Devices Market Segmentation & Coverage
TABLE 2. Global Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 4. Global Chest Tubes (Thoracostomy Tubes) Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Chest Tubes (Thoracostomy Tubes) Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Chest Tubes (Thoracostomy Tubes) Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Needle Decompression Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Needle Decompression Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Needle Decompression Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Thoracic Catheters Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Thoracic Catheters Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Thoracic Catheters Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pneumothorax Valves Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pneumothorax Valves Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pneumothorax Valves Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Surgical and Minimally Invasive Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Surgical and Minimally Invasive Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Surgical and Minimally Invasive Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Ambu Bags with Ventilation Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Ambu Bags with Ventilation Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Ambu Bags with Ventilation Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 23. Global Conservative Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Conservative Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Conservative Treatment Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Needle Aspiration Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Needle Aspiration Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Needle Aspiration Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Chest Drainage Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Chest Drainage Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Chest Drainage Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Surgical Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Surgical Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Surgical Treatment Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 36. Global Pediatric Pneumothorax Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Pediatric Pneumothorax Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Pediatric Pneumothorax Treatment Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Adult Pneumothorax Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Adult Pneumothorax Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Adult Pneumothorax Treatment Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 43. Global Spontaneous Pneumothorax Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Spontaneous Pneumothorax Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Spontaneous Pneumothorax Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Traumatic Pneumothorax Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Traumatic Pneumothorax Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Traumatic Pneumothorax Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Tension Pneumothorax Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Tension Pneumothorax Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Tension Pneumothorax Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Iatrogenic Pneumothorax Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Iatrogenic Pneumothorax Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Iatrogenic Pneumothorax Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Post-Surgical Pneumothorax Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Post-Surgical Pneumothorax Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Post-Surgical Pneumothorax Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Pneumothorax Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Pneumothorax Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. North America Pneumothorax Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. North America Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 66. North America Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 67. North America Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 68. North America Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 69. Latin America Pneumothorax Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Latin America Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 71. Latin America Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 72. Latin America Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 73. Latin America Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. Europe Pneumothorax Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Europe Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 76. Europe Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 77. Europe Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 78. Europe Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. Middle East Pneumothorax Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Middle East Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 81. Middle East Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 82. Middle East Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 83. Middle East Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Africa Pneumothorax Treatment Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Africa Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 86. Africa Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 87. Africa Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 88. Africa Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Global Pneumothorax Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. ASEAN Pneumothorax Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. ASEAN Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 92. ASEAN Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 93. ASEAN Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 94. ASEAN Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. GCC Pneumothorax Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. GCC Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 97. GCC Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 98. GCC Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 99. GCC Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. European Union Pneumothorax Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. European Union Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 102. European Union Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 103. European Union Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 104. European Union Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. BRICS Pneumothorax Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. BRICS Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 107. BRICS Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 108. BRICS Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 109. BRICS Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. G7 Pneumothorax Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. G7 Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 112. G7 Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 113. G7 Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 114. G7 Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. NATO Pneumothorax Treatment Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. NATO Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 117. NATO Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 118. NATO Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 119. NATO Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Global Pneumothorax Treatment Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. United States Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 122. United States Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 123. United States Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 124. United States Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 125. United States Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Canada Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 127. Canada Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 128. Canada Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 129. Canada Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 130. Canada Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. Mexico Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 132. Mexico Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 133. Mexico Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 134. Mexico Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 135. Mexico Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Brazil Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 137. Brazil Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 138. Brazil Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 139. Brazil Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 140. Brazil Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. United Kingdom Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 142. United Kingdom Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 143. United Kingdom Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 144. United Kingdom Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 145. United Kingdom Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Germany Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 147. Germany Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 148. Germany Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 149. Germany Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 150. Germany Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. France Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 152. France Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 153. France Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 154. France Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 155. France Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Russia Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 157. Russia Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 158. Russia Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 159. Russia Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 160. Russia Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Italy Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 162. Italy Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 163. Italy Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 164. Italy Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 165. Italy Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. Spain Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 167. Spain Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 168. Spain Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 169. Spain Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 170. Spain Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. China Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 172. China Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 173. China Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 174. China Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 175. China Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. India Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 177. India Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 178. India Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 179. India Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 180. India Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. Japan Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 182. Japan Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 183. Japan Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 184. Japan Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 185. Japan Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Australia Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 187. Australia Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 188. Australia Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 189. Australia Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 190. Australia Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. South Korea Pneumothorax Treatment Devices Market Size, 2017-2032 (USD Million)
TABLE 192. South Korea Pneumothorax Treatment Devices Market Size, by Type of Device, 2017-2032 (USD Million)
TABLE 193. South Korea Pneumothorax Treatment Devices Market Size, by Treatment Method, 2017-2032 (USD Million)
TABLE 194. South Korea Pneumothorax Treatment Devices Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 195. South Korea Pneumothorax Treatment Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. Global Pneumothorax Treatment Devices Market Share, by Key Player, 2025
TABLE 197. Global Pneumothorax Treatment Devices Market, Key Experts

Companies Mentioned

  • Becton, Dickinson and Company
  • Chembio Diagnostics, Inc.
  • ConvaTec Group Plc
  • Cook Medical Inc.
  • Getinge AB
  • Halyard Health, Inc.
  • Johnson & Johnson
  • Livanova PLC
  • Medi-Globe GmbH
  • Medtronic plc
  • Pneumothorax Solutions, Inc.
  • Smith & Nephew plc
  • Sorin Group
  • Teleflex Incorporated